Urology Devices Market Report 2023 : Future Development, Top Key Players, Share, Size and Forecast to 2028

In August 2023, Fresenius Medical Care AG & Co. KGaA (Germany), announced FDA Clearance for the product Versi HD with GuideMe Software.


pune, Maharashtra -- (SBWIRE) -- 12/11/2023 -- Urology Devices Market in terms of revenue was estimated to be worth $34.1 billion in 2023 and is poised to reach $48.6 billion by 2028, growing at a CAGR of 7.3% from 2023 to 2028 according to a new report by MarketsandMarkets. The high prevalence of urological diseases significantly impacts the increased demand for urological devices. Cancer patients who need surgical interventions with latest technologies like minimally invasive surgery and robotic surgeries. This will lead to an increased need for urological devices. Thus, the escalating demand for urological disease diagnosis and treatment, has led to a pressing need for technologically advanced devices, which is thereby expected to support the growth of the urological devices market.

Report Link:

Browse in-depth TOC on "Urology Devices Market"

159 - Tables
44 - Figures
274 - Pages

In 2022, the instruments segment held the largest share of the urology devices market by product segment.

The urology devices market is segmented into instruments and consumables & accessories based on products. The instruments segment accounted for the largest share of the urology devices market in 2022. This segment covers the most commonly used products, such as dialysis devices, endoscopes, laser & lithotripsy devices, endovision & imaging systems, robotic systems, insufflators, endoscopy fluid management systems, urodynamic systems and other instruments. These products are commonly used in hospitals, dialysis centers and home care settings. As technologies continue to evolve, the efficiency and accuracy of these products contribute significantly to the urological procedures.

The kidney diseases segment held the largest share of the urology devices market by application segment in 2022.

The global urology devices market is differentiated into kidney diseases, urological cancer, pelvic organ prolapse, benign prostatic hyperplasia, urinary incontinence, erectile dysfunction, urinary stones and other applications. In 2022, the kidney diseases segment dominated the urology devices market. The urology devices market in kidney diseases is expected to grow at a high rate owing to the rising incidence of kidney diseases and chronic diseases. With a burgeoning global population, the need for urology devices has significantly increased due to the increased number of procedures required. Hospitals and dialysis centers are at the forefront of this surge, as they cater to routine medical care and handle emergencies.

The hospitals, ASCA & clinics segment held the largest share of the urology devices market by end-user segment in 2022.

The global urology devices market is differentiated into hospitals, ASCS & clinics, dialysis centers and home care settings. In 2022, the hospitals, ASCS & clinics segment dominated the urology devices market. The urology devices market in hospitals is expected to grow at a high rate owing to the increasing number of surgical procedures related to urology care. The expanding network of healthcare institutions directly translates to a substantial market share, reflecting the pivotal role hospitals play in safeguarding patient well-being.

North America is the largest regional market for urology devices market.

The market for urology devices has been divided into five key geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America held the predominant portion of the urology devices market. This can be attributed to the region's advanced healthcare facilities and substantial healthcare investments, which are pivotal in fueling the requirement for urology devices. Moreover, the projected rise in urological procedures is anticipated to contribute to the expansion of the market. As the demand for urological procedures rises, so does the need for precise urological devices to ensure successful and safe procedures.

Inquiry Before Buying:

Urology Devices Market Dynamics:


1. Rising incidence of urological diseases
2. Growing preference for minimally invasive procedures
3. Rising focus on R&D and product launches
4. Growing number of hospitals and surgical centers


1. High degree of consolidation among key players


1. Growing Potential growth opportunities in emerging economies
2. Technological advancements


1. Increasing number of product recalls by key players
2. Shortage of skilled urologists

Key Market Players of Urology Devices Industry:

The major players operating in urology devices market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Cardinal Health (US), Olympus Corporation (Japan), Intuitive Surgical (US), Coloplast A/S (Denmark), Stryker Corporation (US), Teleflex Incorporated (US), Convatec Group PLC (UK), Medtronic PLC (Ireland), Karl Storz (Germany), Cook Medical (US), Richard Wolf GmbH (Germany), CompactCath (US), Dornier MedTech (Germany), Nikkiso Co., Ltd. (Japan), Dialife SA (Switzerland), Erbe Vision (Germany), Well Lead Medical Co., Ltd. (China), ROCAMED (Germany), EndoMed Systems GmbH (Germany), Amniso International, Inc. (US), Medispec (US), Medical Technologies of Georgia (US), Vimex Sp. z o.o. (Poland), Balton Sp. z o.o. (Poland), Hunter Urology (UK), Ribbel International Ltd. (India).

The break-up of the profile of primary participants in the urology devices market:

- By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 – 30%
- By Designation: C-level - 27%, D-level - 18%, and Others - 55%
- By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and Middle East & Africa- 4%

Get 10% Free Customization on this Report:

Urology Devices Market Recent Developments:

- In August 2023, Fresenius Medical Care AG & Co. KGaA (Germany), announced FDA Clearance for the product Versi HD with GuideMe Software.
- In December 2022, Boston Scientific Corporation (US) and Acotec Scientific Holdings Limited (China) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company that offers solutions designed for a variety of interventional procedures.
- In May 2022, B. Braun SE (Germany) entered into a distribution agreement, and B. Braun surgery division Aesculap has strengthened its long-term partnership with True Digital Surgery, a Californian company that is an expert in robotically controlled 3D digital visualization.
- In April 2022, Baxter International, Inc. (US) Announces U.S. FDA Clearance of ST Set used for renal replacement therapy (CRRT)
- In April 2021, Becton, Dickinson and Company (US) announced an investment of USD 65 million for the construction of a state-of-the-art medical facility in Tucson, Arizona (US), which will serve as a final stage manufacturing and sterilization center to improve overall efficiency, customer service, and supply chain in the US.

About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441